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physiologic role of the perineurial barrier. dhh null mice transduction and cell surface receptor expression. Re-
cent studies have suggested that, in some cases, GPCR-may provide a useful model for investigations of the
biological function of this barrier, both in physiologic mediated endocytosis may also be important for mediat-
ing other biological actions of receptor occupancy.and pathologic settings. They may have an ancillary
benefit for investigations of other aspects of peripheral These other actions influenced by receptor endocytosis
may include physiologic responses such as tolerance,nerve development, since the absence of a perineurial
barrier renders the nerves in these mice much more dependence, and even the therapeutic actions of vari-
ous drugs (see Roth et al., 1998, for a recent review).accessible to experimental manipulation. These studies
also raise the question of whether Dhh plays a role in For GPCRs in general, activation is usually followed by
a cascade of events that includes receptor phosphoryla-the development of tight junctions between endothelial
cells within the endoneurium and, by analogy, in the tion, desensitization, and internalization. It has been
clear for some time, however, that efficacy does notblood±brain barrier. Finally, as the initial recruitment of
mesenchymal cells around axon±Schwann cell units in always directly correlate with receptor phosphorylation,
desensitization, and internalization (Keith et al., 1996; Yuembryonic peripheral nerves was unaffected in the dhh
null mice, other signals distinct from Dhh must be in- et al., 1997; see figure). In some cases, even antagonists,
which cannot activate receptors, cause GPCR internal-volved and remain to be identified.
By demonstrating a key role of Schwann cells and Dhh ization (Willins et al., 1999).
With these findings as a backdrop, Whistler et al.in the formation of the perineurium and the nerve±tissue
(1999) present intriguing data in this issue of Neurondiffusion barrier, the authors have opened a new and
which suggest that the differential biological actions ofpromising window into these and other unresolved
drugs may depend, in part, on their abilities to inducequestions of peripheral nerve development.
endocytosis. They use m opioid receptors, which medi-
ate many of the analgesic, rewarding, and addictive
properties of opioids (Matthes et al., 1996), as a modelJames L. Salzer
system in which to probe the consequences of GPCRDepartment of Cell Biology and Neurology
endocytosis.New York University Medical Center
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though morphine, a highly addictive opioid, can activate
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is that, even though chimeric receptors are internalized
after morphine exposure, morphine's relative efficacy
(as measured by GIRK activation) is unaffected. They
then show that the chimeric receptor can also be phos-
phorylated following exposure to morphine, whereas theWhat's All the RAVE
native receptor cannot (see figure).about Receptor Internalization? Following receptor phosphorylation, arrestins are fre-
quently recruited to the plasma membrane, where they
facilitate endocytosis by serving as scaffolding proteins
that bind to clathrin (Ferguson et al., 1996; Goodman etFor some time, it has been assumed that the general
role receptor endocytosis plays in G protein±coupled al., 1996) (see figure). Whistler et al. (1999) find that
morphine fails to cause arrestin translocation from thereceptor (GPCR) actions is in the regulation of signal
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Methadone (Low RAVE) Causes Internalization, While Morphine (High RAVE) Does Not
The top panel shows that methadone causes receptor activation, phosphorylation, arrestin binding, and internalization, whereas morphine,
which activates the m receptor, does not induce phosphorylation or internalization of native m receptors. The bottom panel shows that a m/d
chimeric opioid receptor (d C terminus shown in red) is able to be phosphorylated and internalized following morphine exposure.
cytosol to the plasma membrane for the native m recep- will likely inspire a large number of addiction researchers
to revisit the relevance of receptor internalization fortor, whereas the chimeric receptor efficiently recruits
arrestin to the plasma membrane (see figure) after expo- drug dependence. More importantly, these studies will
also be of interest to investigators who are identifyingsure to morphine. To determine if these results, all ob-
tained in an artificial expression system (HEK 293 cells), the general biological role(s) that endocytosis has in
mediating certain molecular consequences of GPCR ac-are relevant to the regulation of m receptors in neurons,
Whistler et al. (1999) express native and chimeric m re- tivation, such as MAP kinase activation (Daaka et al.,
1998; Ignatova et al., 1999). Thus, for instance, the re-ceptors in primary hippocampal neuronal cultures using
adenovirus-mediated gene transfer. Importantly, the na- sults of Whistler et al. (1999) suggest that if endocytosis
is involved in certain biological and adaptive responsestive receptor was unable to be internalized after mor-
phine exposure, whereas the chimeric receptor was mediated by GPCRs, then individual differences in the
abilities of ligands to induce endocytosis should be re-readily internalized.
To explain these findings, the authors speculate that flected in differential activation of downstream effectors
(e.g., MAP kinase activation and induction of gene tran-a measure they term RAVE might allow investigators to
distinguish among ligands that have differential ultimate scription). For example, as pointed out in the Whistler
et al. (1999) article, methadone and morphine differ inbiological activities. They define RAVE as the relative
activity (efficacy) versus the ability of a ligand to induce their abilities to induce both endocytosis and addiction.
Thus, it is conceivable that other ligands which haveendocytosis. As an example, they report that methadone
and etorphine, which have low propensities to induce different ultimate biological effects (i.e., psychothera-
peutic drugs with different therapeutic efficacies) maytolerance and dependence, have low RAVE values,
whereas morphine, which has a high RAVE, has a have these distinct actions as a direct result of their
differential abilities to produce endocytosis (Willins etmarked propensity to induce tolerance and depen-
dence. Future studies investigating a large number of al., 1999). Finally, the results of Whistler et al. (1999)
imply that manipulating the abilities of GPCRs to beopioids (which differ in their abilities to induce analgesia,
tolerance, and dependence) will be necessary to fully endocytosed, either by pharmacologic or genetic ap-
proaches, could alter the ultimate biological conse-test this interesting notion.
The report by Whistler et al. (1999) is important to quences of receptor activation. That would be some-
thing about which all neuroscientists could RAVE.neurobiologists for several reasons. First, these findings
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